Soleno Therapeutics shares surged 39% in recent Monday trading after the company got breakthrough therapy designation from the US Food and Drug Administration for diazoxide choline to treat.
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37 89 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc. (NASDAQ:AMZN) on Tuesday and Apple Inc.